1. Home
  2. GCTS vs PYPD Comparison

GCTS vs PYPD Comparison

Compare GCTS & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GCT Semiconductor Holding Inc.

GCTS

GCT Semiconductor Holding Inc.

HOLD

Current Price

$1.29

Market Cap

98.6M

Sector

Finance

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.37

Market Cap

81.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCTS
PYPD
Founded
1998
2008
Country
United States
Israel
Employees
126
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.6M
81.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
GCTS
PYPD
Price
$1.29
$4.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$3.50
$12.00
AVG Volume (30 Days)
1.1M
55.9K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1,052.30
N/A
Revenue Next Year
$140.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$2.44
52 Week High
$2.47
$5.12

Technical Indicators

Market Signals
Indicator
GCTS
PYPD
Relative Strength Index (RSI) 56.77 53.04
Support Level $1.28 $4.14
Resistance Level $1.45 $4.38
Average True Range (ATR) 0.09 0.21
MACD 0.01 0.01
Stochastic Oscillator 58.75 77.27

Price Performance

Historical Comparison
GCTS
PYPD

About GCTS GCT Semiconductor Holding Inc.

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. Geographically, operates in South Korea and the United States, with maximum revenue from the USA.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: